Skip to main content
SpringerLink
Log in

Immunosuppressive treatment of rheumatic diseases during pregnancy

  • Chapter
Treatment of Autoimmune Disorders

  • 125 Accesses

Abstract

Rheumatic diseases have a predilection for the female sex and often become manifest during womens, childbearing years. The interaction of pregnancy and rheumatic diseases varies, some conditions benefit, others worsen in response to the immunological and hormonal alterations of pregnancy. Diseases which remain active during pregnancy may need drug treatment either for the benefit of the mother or in order to protect pregnancy and the fetus. Most often, immunosuppressive treatment is required in disorders associated with involvement of internal organs and autoimmune phenomena (Table 1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alstead EM, Ritchie JK, Lennard-Jones JE, Farthing MJG, Clark ML (1990) Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology 99: 443–446

    PubMed  CAS  Google Scholar 

  • Armenti VT, Ahlswede KM, Ahlswede BA, Jarrell BE, Moritz MJ, Burke JF (1994) National transplantation pregnancy registry: outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation 57: 502–506

    PubMed  CAS  Google Scholar 

  • Armenti VT, Moritz MJ, Davison JM (1998) Drug safety issues in pregnancy following transplantation and immunosuppression. Drug Saf 19: 219–232

    Article  PubMed  CAS  Google Scholar 

  • Branch DW, Peaceman AM, Druzin M et al. (2000) A multicenter, placebo-controlled pilot study of intravenous immune globuline treatment of antiphospholipid syndrome during pregnancy. Am J Obstet Gynecol 182: 122–127

    Article  PubMed  CAS  Google Scholar 

  • Briggs GG, Freeman RK, Yaffe SJ (1998) Drugs in pregnancy and lactation, 5th edn. Williams & Wilkins. Baltimore, pp 272c-279c

    Google Scholar 

  • Brent RL (1998) Leflunomide as an example of a modern approach to product labelling for reproductive effects: a category X drug based on pharmacokinetic data. Teratology 58: 445

    Google Scholar 

  • Brent RL (2001) Teratogen update: reproductive risks of leflunomide (Arava), a pyrimidine synthesis inhibitor: counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child. Teratology 63: 106–112

    Article  PubMed  CAS  Google Scholar 

  • Buchanan NMM, Toubi E, Khamashta KE, Lima F, Kerslake S, Hughes GRV (1996) Hy doxy chloroquine and lupus pregnancy: review of a series of 36 cases. Ann Rheum Dis 55: 486–488

    Article  PubMed  CAS  Google Scholar 

  • Cockburn I, Krupp P, Monka C (1989) Present experience of Sandimmun in pregnancy. Transplant Proc 21: 3730–3732

    PubMed  CAS  Google Scholar 

  • Coté CJ, Meuwissen HG, Pickering RJ (1974) Effects on the neonate of prednisone and azathioprine administered to the mother during pregnancy. J Pediatr 85: 324–328

    Article  PubMed  Google Scholar 

  • Davison JM, Dellagrammatikos H, Parkin JM (1985) Maternal azathioprine therapy and depressed haemopoiesis in the babies of renal allograft patients. Br J Obst Gynecol 92: 233–239

    Article  CAS  Google Scholar 

  • Di Paolo S, Schena A, Morrone LF, Manfredi G, Stallone G, Derosa C, Procino A, Schena FP (2000). Immunologic evaluation during the first year of life of infants born to cyclosporine-treated female kidney transplant recipients. Transplantation 69: 2049–2054

    Article  PubMed  Google Scholar 

  • Doll CD, Ringenberg QS, Yarbro JW (1989) Antineoplastic agents and pregnancy. Semin Oncol 16: 337–346

    PubMed  CAS  Google Scholar 

  • Fraser FC, Sajoo A (1985) Teratogenic potential of corticosteroids in humans. Teratology 51: 4546

    Google Scholar 

  • Gaughan WJ, Moritz MJ, Radomski JS, Burke JF Jr, Armenti VT (1996) National Transplantation Pregnancy Registry: report on outcomes in cyclosporine-treated female kidney transplant recipients with an interval from transplant to pregnancy of greater than five years. Am J Kidney Dis 28: 266–269

    Article  PubMed  CAS  Google Scholar 

  • Goroir BP, Peppel K, Silva M, Beutler B (1992) The biosynthesis of tumor necrosis factor during pregnancy: studies with a CAT reporter transgene and TNF inhibitors. Eur Cytokine Network 3: 533–537

    Google Scholar 

  • Harris EN, Pierangeli SS (1998) Utilization of intravenous immunoglobulin therapy to treat recurrent pregnancy loss in the antiphospholipid syndrome: a review. Scand J Rheumatol (Suppl) 107: 97–102

    CAS  Google Scholar 

  • Hart CN, Naunton RF (1964) The ototoxicity of chloroquine phosphate. Arch Otolaryngol Head Neck Surg 80: 407–412

    Article  CAS  Google Scholar 

  • Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA (2000) Folic acid antagonists during pregnancy and the risk of birth defects. N Eng J Med 343: 1608–1614

    Article  CAS  Google Scholar 

  • Katz JA, Lichtenstein GR, Keenan GF, Healy DE, Jacobs SJ (2001) Outcome of pregnancy in women receiving remicade (Infliximab) for the treatment of Crohn’s disease or rheumatoid arthritis. American Gastroenterological Association, Digestive Disease Week, Atlanta, April 2001, Abstract 366

    Google Scholar 

  • Kozlowska-Boszko B, Soluch L, Rybus J, Lao M, Durlik M, Gaciong Z (1996) Does chronic glucosteroid therapy in pregnant renal allograft recipients affect Cortisol levels in neonates? Transplant Proc 28: 3490–3491

    PubMed  CAS  Google Scholar 

  • Kraus AM (1975) Congenital cataract and maternal steroid injection. J Pediatr Ophthalmol Strabismus 12: 107–108

    Google Scholar 

  • Lamarque V, Leleu MF, Monka C, Krupp P (1997) Analysis of 629 pregnancy outcomes in transplant recipients treated with Sandimmun. Transplant Proc 29: 2480

    Article  PubMed  CAS  Google Scholar 

  • Le Thi Huong D, Wechsler B, Bletry O, Vauthier-Brouzes D, Lefebvre G, Piette JC (2001) A study of 75 pregnancies in patients with antiphospholipid syndrome. J Rheumatol 28: 2025–2030

    Google Scholar 

  • Levi S, Liberman M, Levi AJ, Bjarnason I (1988) Reversible congenital neutropenia associated with maternal sulphasalazine therapy (letter). Eur J Pediatr 148: 174–175

    Article  PubMed  CAS  Google Scholar 

  • Levy M, Buskila D, Gladman DD, Urowitz MB, Koren G (1991) Pregnancy outcome following first trimester exposure to chloroquine. Am J Perinatol 8: 174–178

    Article  PubMed  CAS  Google Scholar 

  • Meehan RT, Dorsey JK (1987) Pregnancy among patients with systemic lupus erythematosus receiving immunosuppressive therapy. J Rheumatol 14: 252–258

    PubMed  CAS  Google Scholar 

  • Mirkes PE (1985) Cyclophosphamide teratogenesis: a review. Teratog Carcinog Mutagen 5: 75–88

    Article  PubMed  CAS  Google Scholar 

  • Mogadam M, Dobbins WO, Korelitz BI, Ahmed SW (1981) Pregnancy in inflammatory bowel disease: effect of sulphasalazine and corticosteroids on fetal outcome. Gastroenterology 80: 72–76

    PubMed  CAS  Google Scholar 

  • Østensen M, Hartmann H, Salvesen K (2000) Low dose weekly methotrexate in early pregnancy: a case series and review of the literature. J Rheumatol 27: 1872–1875

    PubMed  Google Scholar 

  • Parke AL (1988) Antimalarial drugs, systemic lupus erythematosus and pregnancy. J Rheumatol 15: 607–610

    PubMed  CAS  Google Scholar 

  • Parke AL, West B (1996) Hy doxy chloroquine in pregnant patients with systemic lupus erythematosus. J Rheumatol 23: 1715–1718

    PubMed  CAS  Google Scholar 

  • Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L, Friesen MH, Jacobson S, Kasapinovic S, Chang D, Diav-Citrin O, Chitayat D, Nulman I, Einarson TR, Koren G (2000) Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 62: 385–392

    Article  PubMed  CAS  Google Scholar 

  • Petri M (1998) Pregnancy and SLE. Baillieres Clin Rheumatol 12: 449–476

    Article  PubMed  CAS  Google Scholar 

  • Phillips-Howard PA, Wood D (1996) The safety of antimalarial drugs in pregnancy. Drug Saf 14: 131–145

    Article  PubMed  CAS  Google Scholar 

  • Pilarski LM, Yacyshyn BR, Lazarovits AI (1994) Analysis of peripheral blood lymphocyte populations and immune function from children exposed to cyclosporine or to azathioprine in utero. Transplantation 57: 133–144

    Article  PubMed  CAS  Google Scholar 

  • Pinsky L, DiGeorge AM (1965) Cleft palate in the mouse: a teratogenic index of glucocorticoid potency. Science 147: 402–403

    Article  PubMed  CAS  Google Scholar 

  • Ramsey-Goldman R, Mientus JM, Kutzer JE, Mulvihill JJ, Medsger TA (1993) Pregnancy outcome in women with systemic lupus erythematosus treated with immunosuppressive drugs. J Rheumatol 20: 1152–1157

    PubMed  CAS  Google Scholar 

  • Registration Committee of the European Dialysis and Transplant Association (1980) Successful pregnancies in women treated by dialysis and kidney transplantation. Br J Obstet Gynaecol 87: 839–845

    Article  Google Scholar 

  • Reinisch JM, Simon NG (1978) Prenatal exposure to prednisone in humans and animals retards intrauterine growth. Science 202: 436–438

    Article  PubMed  CAS  Google Scholar 

  • Schleuning M, Clemm C (1987) Chromosomal aberrations in a newborn whose mother received cytotoxic treatment during pregnancy. N Engl J Med 317: 1666–1667

    PubMed  CAS  Google Scholar 

  • Scott JR (1977) Fetal growth retardation associated with maternal administration of immunosuppressives. Am J Obstet Gynecol 128: 668–676

    PubMed  CAS  Google Scholar 

  • Shaheen FAM, Al-Sulaiman MH, Al-Khader AA (1993) Long-term nephrotoxicity after exposure to cyclosporine in utero. Transplantation 56: 224–225

    Article  PubMed  CAS  Google Scholar 

  • Stanley CW, Gottlieb R, Zager R, Eisenberg J, Richmond R, Moritz MJ, Armenti VT (1999) Developmental well-being in offspring of women receiving post-renal transplant. Transplant Proc 31: 241–242

    Article  PubMed  CAS  Google Scholar 

  • Williamson RA, Karp LE (1981) Azathioprine teratogenicity: review of the literature and case report. Obstet Gynecol 58: 247–250

    PubMed  CAS  Google Scholar 

  • Willoughby CP, Truelove SC (1980) Ulcerative colitis and pregnancy. Gut 21: 469–474

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rheumatology and Clinical Immunology/Allergology, University Hospital, Berne, 3010, Switzerland

    Monika Østensen

Authors
  1. Monika Østensen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Hautkrankheiten, Universitätsklinikum Leipzig, Leipzig, Federal Republic of Germany

    Michael Sticherling

  2. Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Kiel, Kiel, Federal Republic of Germany

    Enno Christophers

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Wien

About this chapter

Cite this chapter

Østensen, M. (2003). Immunosuppressive treatment of rheumatic diseases during pregnancy. In: Sticherling, M., Christophers, E. (eds) Treatment of Autoimmune Disorders. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6016-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6016-9_10

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-7288-9

  • Online ISBN: 978-3-7091-6016-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation